Optometry News

The FDA granted rare pediatric disease designation to ATSN-201, a gene therapy candidate for the treatment of X-linked retinoschisis, according to a press release from Atsena Therapeutics.

In this Healio video, Jeff Todd, president and CEO at Prevent Blindness, discusses the organization’s art therapy program, which was created to help patients with thyroid eye disease cope with feelings of isolation, anxiety and depression.

Vitreoretinal surgery fellows tend to become faster at peeling over the course of their fellowship, according to a study presented at the American Society of Retina Specialists annual meeting.

In this Healio Video Perspective from the ASRS meeting, Ashkan M. Abbey, MD, of Texas Retina Associates discusses 36-month real-world data on the Yutiq implant for the treatment of chronic noninfectious uveitis.

In June, the House Energy and Commerce Committee published recommendations to reform the NIH, including consolidating the National Eye Institute into a Neurological Science and Brain Institute.

Spencer Trask & Co. announced the launch of Signal12, a clinical-stage dry eye company that plans to advance Pro-ocular for the treatment of dry eye disease, according to a press release.

In this episode, Dagny Zhu, MD, and Cathleen McCabe, MD, discuss the unpredictable path of careers, leadership in management and opportunities for growth with Nikie Walker, EdD.

Healio spoke with Bradley Dougherty, OD, PhD, associate professor at The Ohio State University College of Optometry, about how socioeconomic factors can affect the diagnosis, treatment and outcomes of age-related macular degeneration.

A questionnaire found that the majority of retina fellows planned to go into a retina-only private practice.

The progression of vision loss among patients with neovascular glaucoma appeared linked to factors such as the disease stage at diagnosis, age, sex, a history of type 2 diabetes and insurance status, according to study results.